Reduction of monoclonal antibody viscosity using interpretable machine learning

Article Properties

• Language

  English
• DOI (url)

  10.1080/19420862.2024.2303781
• Publication Date

  2024/03/12
• Journal

  mAbs
• Indian UGC (journal)
• Refrences

  52
• Emily K. Makowski Department of Pharmaceutical Sciences, University of Michigan, Ann Arbor, MI, USABiointerfaces Institute, University of Michigan, Ann Arbor, MI, USA
• Hsin-Ting Chen Biointerfaces Institute, University of Michigan, Ann Arbor, MI, USADepartment of Chemical Engineering, University of Michigan, Ann Arbor, MI, USA
• Tiexin Wang Biointerfaces Institute, University of Michigan, Ann Arbor, MI, USADepartment of Chemical Engineering, University of Michigan, Ann Arbor, MI, USA
• Lina Wu Biointerfaces Institute, University of Michigan, Ann Arbor, MI, USADepartment of Chemical Engineering, University of Michigan, Ann Arbor, MI, USA
• Jie Huang Department of Pharmaceutical Sciences, University of Michigan, Ann Arbor, MI, USABiointerfaces Institute, University of Michigan, Ann Arbor, MI, USA
• Marissa Mock Therapeutic Discovery, Research, Amgen Inc, Thousand Oaks, CA, USA
• Patrick Underhill Department of Chemical and Biological Engineering, Rensselaer Polytechnic Institute, Troy, NY, USA
• Emma Pelegri-O’Day Therapeutic Discovery, Research, Amgen Inc, Thousand Oaks, CA, USA
• Erick Maglalang Drug Product Technologies, Amgen Inc, Thousand Oaks, CA, USA
• Dwight Winters Therapeutic Discovery, Research, Amgen Inc, Thousand Oaks, CA, USA
• Peter M. Tessier Department of Pharmaceutical Sciences, University of Michigan, Ann Arbor, MI, USABiointerfaces Institute, University of Michigan, Ann Arbor, MI, USADepartment of Chemical Engineering, University of Michigan, Ann Arbor, MI, USADepartment of Biomedical Engineering, University of Michigan, Ann Arbor, MI, USA ORCID (unauthenticated)